Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,371.90
+13.20 (0.97%)
May 6, 2026, 3:30 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 188.24 billion as of May 6, 2026. Its market cap has decreased by -0.17% in one year.
Market Cap
188.24B
Enterprise Value
215.50B
Revenue
30.65B
Ranking
n/a
PE Ratio
42.96
Stock Price
1,371.90
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 188.24B, an increase of 127.60%. That is a compound annual growth rate of 9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 188.24B | -8.22% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 388.40B |
| Ajanta Pharma | 352.52B |
| Emcure Pharmaceuticals | 318.53B |
| Gland Pharma | 288.46B |
| Wockhardt | 226.77B |
| Piramal Pharma | 214.94B |
| NATCO Pharma | 196.26B |
| Cohance Lifesciences | 184.88B |